¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"transition state intermediate"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • intermediate product
    Áß°£»ê¹°
  • intermediate ray
    Áß°£¹æ»ç¼±
  • intermediate reaction
    Áß°£¹ÝÀÀ
  • intermediate trait
    Áß°£¼ºÇâ(¼ÒÁú)
  • intermediate-acting insulin
    Áß°£ÀÛ¿ëÀν¶¸°
  • reactive intermediate
    ¹ÝÀÀÁß°£¹°Áú
  • replicative intermediate
    º¹Á¦Áß°£»ê¹°
  • anxiety state
    ºÒ¾È»óÅÂ
  • acute confusional state
    ±Þ¼ºÈ¥µ·»óÅÂ
  • basal state
    ±âÃÊ»óÅÂ
  • clouded state
    ȥŹ»óÅÂ
  • condensed state
    ÃàÇÕ»óÅÂ
  • correlated state
    »ó°ü»óÅÂ
  • critical state
    ÀÓ°è»óÅÂ
  • carrier state
    º¸±Õ»óÅÂ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • intermediate nephron
    Áß°£ÄáÆÏ´ÜÀ§
  • intermediate nerve
    Áß°£½Å°æ
  • intermediate product
    Áß°£»ê¹°, Áß°£´ë»ç¹°
  • intermediate ray
    Áß°£¹æ»ç¼±
  • intermediate reaction
    Áß°£¹ÝÀÀ
  • intermediate spermatogonium
    Áß°£Á¤Á¶¼¼Æ÷
  • intermediate variable
    Áß°£º¯¼ö
  • intermediate density lipoprotein
    Á߹еµÁöÁú´Ü¹é
  • intermediate cell mass
    Áß°£¼¼Æ÷µ¢ÀÌ
  • intermediate field magnetic resonance scanner
    ÁßµîÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • reactive intermediate
    ¹ÝÀÀÁß°£¹°Áú
  • replicative intermediate
    º¹Á¦Áß°£»ê¹°
  • posterior intermediate sulcus
    µÚÁß°£°í¶û
  • accessory state
    µ¡»óÅÂ
  • acute confusional state
    ±Þ¼ºÈ¥µ·»óÅÂ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Present State Examination
    Çö»óŰ˻磨úÞßÈ÷¾ËþÞÛ£©
  • SSFP ( steady state free precession)
    Ç×Á¤ »óÅ ÀÚÀ¯ ¼¼Â÷
  • accessory state
    µ¡»óÅÂ
  • acute confusional state
    ±Þ¼º È¥µ· »óÅÂ
  • adult ego state
    ¼ºÀÎ ÀھƻóÅÂ
  • allergic state
    ¾Ë·¹¸£±â»óÅÂ(ÊÙË×̬).
  • allergic state
    ¾Ë·¹¸£±â»óÅÂ, °ú¹Î»óÅÂ
  • anxiety state
    ºÒ¾È»óÅÂ.
  • anxiety tension state
    ºÒ¾È, ±äÀå»óÅÂ(ÑÌíåßÒ÷¾).
  • ground state
    ±âÀú»óÅÂ(Ðñî¼ßÒ÷¾).
  • hepatitis,carrier state
    º¸±ÕÀÚ(ÜÁжíº)
  • hypercoagulable state
    °úÀÀ°í»óÅÂ
  • hyperdynamic state
    °ú¿ªµ¿»óÅÂ.
  • hyperimmune state
    °ú¸é¿ª»óÅÂ.
  • hyperimmune state
    °ú¸é¿ª»óÅÂ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • gigantocellular intermediate reticular nucleus
    °Å´ë¼¼Æ÷Áß°£±×¹°ÇÙ
  • inferior pontine intermediate reticular nuleus
    ¾Æ·¡´Ù¸®³úÁß°£±×¹°ÇÙ
  • intermediate
    Áß°£(ñéÊà)ÀÇ, Áß°£¹°(ñéÊàÚª).
  • intermediate
    Áß°£
  • intermediate acting
    Á߽ð£Àۿ뼺(ñéãÁÊàíÂéÄàõ)ÀÇ, Áß°£Àۿ뼺ÀÇ.
  • intermediate atrial branch
    Áß°£½É¹æ°¡Áö
  • intermediate body
    Áß°£¼Òü
  • intermediate branch
    Áß°£°¡Áö
  • intermediate callus
    °£ÆÇ°ñ(Êà÷ùÍé).
  • intermediate cell
    Áß°£¼¼Æ÷.
  • intermediate cell mass
  • intermediate cervical septum
    Áß°£¸ñ»çÀ̸·
  • intermediate cervical sympathetic ganglion
  • intermediate coat
    Áß°£Ãþ(ñéÊàöµ).
  • intermediate coupling
    Áß°£°áÇÕ.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Intermediate line
    Áß°£´É¼±
    [¿¾ ¿ë¾î] Áß°£¼±
  • Intermediate lymph nodes
    Áß°£¸²ÇÁÀý
    [¿¾ ¿ë¾î] Áß°£ÀÓÆÄÀý
  • Intermediate cervical septum
    Áß°£¸ñ»çÀ̸·
    [¿¾ ¿ë¾î] Áß°£°æºÎÁß°Ý
  • Intermediate dorsal cutaneous nerve
    Áß°£¹ßµîÇǺνŰæ
    [¿¾ ¿ë¾î] ÁßÁ·¹èÇǽŰæ
  • Intermediate ventral nucleus
    Áß°£¹èÂÊÇÙ
    [¿¾ ¿ë¾î] Áß°£º¹ÃøÇÙ
  • Intermediate part
    Áß°£ºÎºÐ
    [¿¾ ¿ë¾î] Áß°£ºÎ
  • Intermediate part [Red part]
    Áß°£ºÎºÐ
    [¿¾ ¿ë¾î] Áß°£ºÎ
  • Intermediate supraclavicular nerves
    Áß°£ºøÀåÀ§½Å°æ
    [¿¾ ¿ë¾î] Áß°£¼â°ñ»ó½Å°æ
  • Intermediate body
    Áß°£¼Òü
    [¿¾ ¿ë¾î] Áß°£¼Òü
  • Intermediate ganglia
    Áß°£½Å°æÀý
    [¿¾ ¿ë¾î] Á߽ŰæÀý
  • Intermediate atrial branch
    Áß°£½É¹æ°¡Áö
    [¿¾ ¿ë¾î] Áß°£½É¹æÁö
  • Intermediate cuneiform bone
    Áß°£½û±â»À
    [¿¾ ¿ë¾î] Áß°£¼³»ó°ñ
  • Intermediate sacral crest
    Áß°£¾ûÄ¡»À´É¼±
    [¿¾ ¿ë¾î] Áß°£Ãµ°ñ¸ª
  • Intermediate spermatogonia
    Áß°£Á¤Á¶¼¼Æ÷
    [¿¾ ¿ë¾î] Áß°£Á¤Á¶¼¼Æ÷
  • Intermediate spermatogonium
    Áß°£Á¤Á¶¼¼Æ÷
    [¿¾ ¿ë¾î] Áß°£Á¤Á¶¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • transition
    "õÀÌ (ôÃì¹), ¿°±âÀüȯ (ç¤Ðñï®üµ)"
  • transition dipole moment
    õÀÌ ½Ö±ØÀÚ(ôÃì¹äªÐ¿í­)¸ð¸àÆ®
  • transition element
    õÀÌ¿ø¼Ò(ôÃì¹êªáÈ)
  • transition temperature
    õÀ̿µµ(ôÃì¹è®Óø)
  • vibrational transition
    Áøµ¿ õÀÌ(òÉÔÑôÃì¹)
  • vibronic transition
    Áøµ¿ õÀÌ(òÉÔÑôÃì¹)
  • aneuploid state
    À̼öü»óÅÂ(ì¶â¦ô÷ßÒ÷¾)
  • diploid state
    À̹èü(ì£ÛÆô÷)
  • equation of state
    »óÅ ¹æÁ¤½Ä (ßÒ÷¾Û°ïïãÒ)
  • exicted state
    µé¶á »óÅÂ(ßÒ÷¾)
  • function of state
    »óÅ ÇÔ¼ö(ßÒ÷¾ùÞâ¦)
  • ground state
    ¹Ù´Ú »óÅÂ(ßÒ÷¾)
  • haploid state
    ÀϹèü »óÅÂ(ìéÛÃô÷»óÅÂ)
  • heteroploid state
    À̼ö »óÅÂ(ì¶â¦ßÒ÷¾)
  • hyperploid state
    °ú¹è¼ö »óÅÂ(ΦÛÃâ¦ßÒ÷¾)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • steady state coherent sequence
    Ç×Á¤»óŰáÁý¿¬¼â
  • steady state free precession [=SSFP]
    Ç×Á¤»óÅÂÀÚÀ¯¼¼Â÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DOUBTFUL double quantum transition for finding unresolved lines
GNTP Graduate Nurse Transition Program
IT immunological test; immunotherapy; implantation test; individual therapy; information technology; in...
Tg glass transition temperature
TP temperature and pressure; temperature probe; temporal peak; temporoparietal; tension pneumothorax; t...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
TP1 Transition protein 1
TP2 Transition protein 2
MPT membrane permeability transition
PT permeability transition
MTP permeability transition pore
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • replicative intermediate
    º¹Á¦ Áß°£Çü
  • active state
    Ȱµ¿ »óÅÂ
    ±ÙÀ°ÀÌ ¼öÃàÇÒ ¶§, ¼öÃà¿ä¼Ò ÀÚü¿¡ ÀϾ°í ÀÖ´Â ¿ªÇÐÀû »óÅÂÀÌ´Ù. ±ÙÀ° ÀÚü¿¡ ź¼º¿ä¼Ò°¡ Á¸ÀçÇϹǷΠ´Ü¼øÇÑ ¼öÃà°î¼±ÀÇ ±â·ÏÀ¸·Î Ȱµ¿»óȲÀ» ¾Ë ¼ö ¾ø´Ù. ¼öÃà¿ä¼Ò´Â ±ÙÀ°ÀÌ ÀڱصǸé Áï½Ã Ȱµ¿»óŰ¡ µÇ°í, Á¦2, Á¦3ÀÇ ÀÚ±ØÀÌ °¡ÇØÁ®µµ ÀÌ È°µ¿»óÅ´ °­È­µÇÁö ¾Ê°í ´Ü¼øÈ÷ Áö¼Ó½Ã°£ÀÌ ¿¬ÀåµÉ »ÓÀÌ´Ù.
  • allergic state
    ¾Ë·¹¸£±â »óÅÂ
    Ven Pirquet´Â Ç׿ø ¹°Áú¿¡ ´ëÇÏ¿© º¯È­ÇÑ ¹ÝÀÀ ´É·ÂÀ» °¡Áö°í ÀÖ´Â »óŸ¦ ¾Ë·¹¸£±â »óŶó°í ºÒ·¶À¸³ª ÇöÀç´Â °íÃÊ¿­À̳ª õ½Ä µîÀÇ ¾ÆÅäÇǼº Áúȯ°ú °°ÀÌ ¾Ë·¹¸£±â°¡ ¿øÀÎÀÌ µÇ´Â Áúȯ¿¡ ´ëÇØ¼­¸¸ »ç¿ëµÈ´Ù.
  • basal state
    ±âÃÊ »óÅÂ
  • central excitatory state
    ÁßÃß ÈïºÐ »óÅÂ
  • correlated state
    »ó°ü »óÅÂ
  • critical state
    ÀÓ°è »óÅÂ
  • dental care councils of state dental association
    ÁÖ Ä¡°úÀÇ»çÇùȸ
  • emotional state
    Á¤¼­ »óÅÂ
  • epileptic state
    °£Áú »óÅÂ
  • equation of state
    »óÅ ¹æÁ¤½Ä
  • excitation state
    ¿©±â »óÅÂ, ÈïºÐ »óÅÂ
  • fast imaging with steady state precession
    Ç×Á¤ »óÅ ¼¼Â÷ ¿îµ¿À» ÀÌ¿ëÇÑ °í¼Ó ¿µ»ó
  • fear state
    °øÆ÷ »óÅÂ
  • Fourier acquisition in the steady state sequence
    Ç×Á¤ »óÅ¿¡¼­ÀÇ Fourier ȹµæ ¿¬¼â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
apallic state Diffuse, bilateral cerebral cortical degeneration caused by head injury, anoxia, or encephalitis, a state of persistent unresponsiveness, such as akinetic mutism, caused by brain damage.
See: vegetative.
Synonym: apallic syndrome, apallic.
(05 Mar 2000)
carrier state A condition in which a human who is not himself sick harbors an infective organism which may cause disease in those to whom it is transmitted.
(12 Dec 1998)
refractory state Subnormal excitability immediately following a response to previous excitation; the state is divided into absolute and relative phases.
(05 Mar 2000)
central excitatory state The building up of excitatory influences produced by individual impulses finally causes firing of the next neuron.
(05 Mar 2000)
perfect state In fungi, that portion of the life cycle in which spores are formed after nuclear fusion.
(05 Mar 2000)
mental state <clinical sign, psychiatry> A finding on physical examination that may refer to any number of abnormal changes in baseline mental functioning.
Milder examples include mood changes, irritability, personality changes, depression or blunted affect. Advanced changes include confusion, lethargy, sleepiness, hallucinations, unresponsiveness and coma.
(27 Sep 1997)
ground state <chemistry, radiobiology> The state of a nucleus, atom or molecule at its lowest energy. All other states are excited.
(16 Dec 1997)
persistent vegetative state A persistent loss of upper cortical function that may follow acute (e.g., infections, toxins, trauma or vascular) events or chronic (e.g., degenerative) events. The patient is bedridden and nutritional support is completely passive, either parenteral or via nasogastric tube. The patient does not require respiratory support or circulatory assistance for survival and is in a state of chronic wakefulness without awareness which may be accompanied by spontaneous eye opening, grunts or screams, brief smiles, sporadic movement of facial muscles and limbs. While the eyes blink upon stimulation, they do not do so in response to visual threats. Some patients chew or clamp their teeth. Urinary and faecal incontinence is universal.
(12 Dec 1998)
convulsive state <disease, neurology> The paroxysmal transient disturbances of brain function that may be manifested as episodic impairment or loss of consciousness, abnormal motor phenomena, psychic or sensory disturbances or perturbation of the autonomic nervous system.
Symptoms are due to paroxysmal disturbance of the electrical activity of the brain. On the basis of origin, epilepsy is idiopathic (cryptogenic, essential, genetic) or symptomatic (acquired, organic). On the basis of clinical and electroencephalographic phenomenon, four subdivisions are recognised:
1. Grand mal epilepsy (major epilepsy, haut mal epilepsy) subgroups: generalised, focal (localised), jacksonian (rolandic)
2. Petit mal epilepsy
3. Psychomotor epilepsy (temporal lobe epilepsy, psychic, psychic equivalent or variant) subgroups: psychomotor proper (tonic with adversive or torsion movements or masticatory phenomena), automatic (with amnesia) and sensory (hallucinations or dream states or d‚j. Vu)
4. Autonomic epilepsy (diencephalic), with flushing, pallor, tachycardia, hypertension, perspiration or other visceral symptoms.
Synonym: epilepsia.
Origin: Gr. Epilepsia = seizure
(14 May 1997)
post-ictal state A period of confusion, lethargy and deep breathing that may last for 15 minutes to several hours after the cessation of a generalised seizure.
(27 Sep 1997)
post-steady state Any period of time, particularly in an enzyme-catalyzed reaction, after the steady-state interval; e.g., when the rate of product formation is declining in an enzyme-catalyzed reaction.
(05 Mar 2000)
pre-steady state Those conditions and the time interval prior to establishment of steady state.
(05 Mar 2000)
hospitals, state Hospitals controlled by agencies and departments of the state government.
(12 Dec 1998)
singlet state A transient, excited state of a molecule (e.g., of chlorophyll, upon absorbing light) that can release energy as heat or light (fluorescence) and thus return to the initial (ground) state; it may alternatively assume a slightly more stable, but still excited state (triplet state), with an electron still dislocated as before but with reversed spin.
(05 Mar 2000)
hypnoid state A drowsy or sleeplike state artificially induced by a hypnotist in individuals of higher than average levels of suggestibility.
See: hypnosis.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Bear State
    arkansasÁÖÀÇ µý À̸§
  • Beehive State
    Utah ÁÖÀÇ µý À̸§
  • Centennial State
    ¹Ì±¹ ColoradoÁÖÀÇ ¼ÓĪ
  • Coal State
    PennsylvaniaÁÖÀÇ ¼ÓĪ
  • Constitution State
    ¹Ì±¹ ConnecticutÁÖÀÇ ¼ÓĪ
  • Cornhusker State
    NebraskaÁÖÀÇ ¼ÓĪ
  • Cotton State
    ¹Ì±¹ AlabamaÁÖÀÇ ¼ÓĪ
  • Cowboy State
    ¹Ì±¹ Wyoming ÁÖÀÇ ¼ÓĪ
  • Coyote State
    ¹Ì±¹ South DakotaÁÖÀÇ ¼ÓĪ
  • Cracker State
    ¹Ì±¹ GeorgiaÁÖÀÇ ¼ÓĪ
  • Creole State
    ¹Ì±¹ LouisianaÁÖÀÇ ¼ÓĪ
  • Eastern state
    (¹Ì)µ¿ºÎÀÇ ¿©·¯ ÁÖ
  • Empire State
    New YorkÁÖÀÇ ¼ÓĪ
  • Empire State Building
    ¿¥ÆÄÀÌ¾î ½ºÅ×ÀÌÆ® ºôµù(´º¿å½Ã¿¡ ÀÖ´Â,Áö»ó102ÃþÀÇ °íÃþ °Ç¹°,ÅÚ·¹ºñÁ¯ žÀ» Æ÷ÇÔÇÑ ³ôÀ̴¾à 449¹ÌÅÍ)
  • Equality State
    ¹Ì±¹ WyomingÁÖÀÇ ¼ÓĪ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á